GENOME ANNOUNCEMENT {#s0}
===================

The mononegaviral family *Rhabdoviridae* currently includes 13 genera and four unassigned species ([@B1]). One of these genera, *Tibrovirus*, includes two species: Bivens Arm virus (BAV) and Tibrogargan virus (TIBV) have been assigned to the species *Tibrogargan tibrovirus*, and Coastal Plains virus (CPV) has been assigned to the species *Coastal Plains tibrovirus* ([@B1][@B2][@B3]). TIBV and BAV were originally isolated from biting midges (*Culicoides brevitarsis* and *C. insignis*, respectively), and CPV from an apparently healthy steer ([@B4][@B5][@B6]). Recently, several novel viruses have been identified as putative tibroviruses. These include (a) Bas-Congo virus (BASV) in the serum of a human with viral hemorrhagic fever ([@B7]), (b) Ekpoma virus 1 (EKV-1) and Ekpoma virus 2 (EKV-2) in sera of apparently healthy humans ([@B8]), and (c) Sweetwater Branch virus (SWBV) in biting midges (*Culicoides insignis*) ([@B3], [@B6]). These viruses have recently been accepted by the International Committee on Taxonomy of Viruses (ICTV) to represent the novel species *Bas Congo tibrovirus*, *Ekpoma 1 tibrovirus*, *Ekpoma 2 tibrovirus*, and *Sweetwater Branch tibrovirus*, respectively ([@B9]). All tibroviruses have the specific genomic structure 3′-N-P-M-U1-U2-G-U3-L-5′, with N-P-M-G-L being canonical rhabdoviral genes encoding structural proteins and U1, U2, and U3 being tibrovirus-unique genes. U1 and U2 encode proteins of unknown function, and U3 encodes a protein with the structural characteristics of a viroporin ([@B3], [@B9], [@B10]).

Beatrice Hill virus (BHV) was first reported in 1984 as a novel virus of biting midges (*Culicoides peregrinus*) that had been collected at Beatrice Hill, Northern Territory, Australia ([@B11]). In 2016, Huang et al. reported a 5,734 nt-long contig of the BHV genome, which indicated that this virus most likely falls into the *Tibrovirus* clade ([@B12]). To determine the taxonomic position of BHV, we obtained a historical sample of brain tissue from a laboratory mouse that had been infected intracranially with BHV-containing material. Viral RNA from this sample was processed and sequenced to obtain the complete genome using a sequence-independent single-primer amplification (SISPA) protocol that included rapid amplification of cDNA ends (RACE) ([@B13]). Resulting libraries were sequenced on an Illumina MiSeq desktop sequencer. Illumina and SISPA-RACE adapter sequences were trimmed from the sequencing reads using Cutadapt version 1.2.1 ([@B14]), quality filtering was conducted with Prinseq-lite ([@B15]), and reads were assembled into contigs using Ray Meta with a *k*-mer length of 25 ([@B16]). Resultant contigs were aligned to the National Center for Biotechnology Information (NCBI) sequence database using BLAST. Reads were aligned back to the assembled BHV sequence using Bowtie2 ([@B17]), and custom scripts were used to generate a final consensus sequence.

Using PASC ([@B18]), the determined complete BHV genome sequence was found to be 72.79% identical to that of TIBV (GenBank accession no. GQ294472.1) and 72.48% identical to that of BAV (KP688373.1). The genome organization matches that of all tibroviruses, therefore confirming Huang et al.'s hypothesis that BHV is a tibrovirus. Our data furthermore suggest that this virus should be assigned to a novel species ("*Beatrice Hill tibrovirus*") based on its divergence from TIBV and BAV.
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--------------------

The GenBank accession number of Beatrice Hill virus isolate CSIRO 25 is [KY073493](https://www.ncbi.nlm.nih.gov/nuccore/KY073493).
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